Meghana Keshavan Follow

Every article

1. Monday, October 5, 2026

2. 13:55health
   STAT+: Lilly’s Jaypirca approved as first-line CLL therapy STAT by Meghana Keshavan

3. Friday, October 2, 2026

4. 13:58health
   STAT+: Lilly bypasses Australian pharmacies with DTC model STAT by Meghana Keshavan

5. Thursday, October 1, 2026

6. 15:22health
   STAT+: A journey to witness China’s biotech boom up close STAT by Meghana Keshavan

7. Tuesday, September 29, 2026

8. 13:52health
   STAT+: AstraZeneca invests $2 billion in Summit Therapeutics STAT by Meghana Keshavan story

9. Monday, September 28, 2026

10. 13:40health
    STAT+: AbbVie wins FDA nod for Parkinson’s pill STAT by Meghana Keshavan

11. Friday, September 25, 2026

12. 15:25health
    STAT+: Lilly wins approval for once-weekly insulin shot STAT by Meghana Keshavan story

13. Thursday, September 24, 2026

14. 13:52health
    STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit STAT by Meghana Keshavan

15. Friday, September 18, 2026

16. 13:42health
    STAT+: Roche expands its Boston footprint with new research center STAT by Meghana Keshavan, Adam Feuerstein story

17. Thursday, September 17, 2026

18. 14:30health
    STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom STAT by Meghana Keshavan, Elaine Chen story

19. Monday, September 14, 2026

20. 13:34health
    STAT+: GSK touts lung cancer data from two drugs STAT by Meghana Keshavan

21. Friday, September 11, 2026

22. 13:39health
    STAT+: Cancer drug shortages keep disrupting patient care STAT by Meghana Keshavan

23. Thursday, September 10, 2026

24. 13:36health
    STAT+: FDA expands Bayer lung cancer drug approval STAT by Meghana Keshavan story

25. Tuesday, September 8, 2026

26. 14:09health
    STAT+: FDA approves AstraZeneca breast cancer drug STAT by Meghana Keshavan story